Heron Therapeutics to Present at Several Upcoming Virtual Investor Conferences

Rhea-AI Summary

Heron Therapeutics, Inc. (Nasdaq: HRTX), a biotechnology company focused on enhancing patient care, announced that CEO Barry Quart will present at two key virtual investor conferences. The presentations are scheduled for the SVB Leerink 10th Annual Global Healthcare Conference on February 24, 2021, at 5:00 pm ET, and the Cowen 41st Annual Healthcare Conference on March 1, 2021, at 11:40 am ET. Live webcasts will be available on the company's website, with replays accessible for 60 days. Heron is dedicated to addressing significant patient needs, particularly in pain and cancer management.

SAN DIEGO, Feb. 17, 2021 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced that Barry Quart, Pharm.D., Chairman and Chief Executive Officer of Heron Therapeutics, will present at the following virtual investor conferences:

• SVB Leerink 10^th Annual Global Healthcare Conference: Wednesday, February 24, 2021 at 5:00 pm ET
• Cowen 41^st Annual Healthcare Conference: Monday, March 1, 2021 at 11:40 am ET

A live webcast of each presentation will be available on the Company's website at www.herontx.com in the Investor Resources section. A replay of each presentation will be archived on the site for 60 days.

About Heron Therapeutics, Inc.

Heron Therapeutics, Inc. is a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs. Heron is developing novel, patient-focused solutions that apply its innovative science and technologies to already-approved pharmacological agents for patients suffering from pain or cancer. For more information, visit www.herontx.com.

Forward-Looking Statements 

This news release contains "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995. Heron cautions readers that forward-looking statements are based on management's expectations and assumptions as of the date of this news release and are subject to certain risks and uncertainties that could cause actual results to differ materially. These risks and uncertainties include, but are not limited to, risks and uncertainties identified in the Company's filings with the Securities and Exchange Commission. Forward-looking statements reflect our analysis only on their stated date, and Heron takes no obligation to update or revise these statements except as may be required by law.

Investor Relations and Media Contact:

David Szekeres
Executive Vice President, Chief Operating Officer
Heron Therapeutics, Inc.
dszekeres@herontx.com
858-251-4447

View original content:http://www.prnewswire.com/news-releases/heron-therapeutics-to-present-at-several-upcoming-virtual-investor-conferences-301230369.html

SOURCE Heron Therapeutics, Inc.

FAQ

What is the schedule for Heron Therapeutics' presentations at upcoming investor conferences?

Heron Therapeutics will present at the SVB Leerink 10th Annual Global Healthcare Conference on February 24, 2021, at 5:00 pm ET, and at the Cowen 41st Annual Healthcare Conference on March 1, 2021, at 11:40 am ET.

Where can I watch the live webcasts of Heron Therapeutics' investor presentations?

The live webcasts of Heron Therapeutics' presentations can be viewed on the company's website under the Investor Resources section.

How long will the replays of the presentations from Heron Therapeutics be available?

Replays of the presentations will be accessible on the Heron Therapeutics website for 60 days after the events.

What does Heron Therapeutics focus on as a biotechnology company?

Heron Therapeutics is focused on developing best-in-class treatments that address significant unmet patient needs, particularly for pain and cancer.